AICHER, THOMAS DANIEL,BOYD, STEVEN ARMEN,CHICARELLI, MARK JOSEPH,CONDROSKI, KEVIN RONALD,FELL, JAY BRADFORD,FISCHER, JOHN P.,GUNAWARDANA, INDRANI W.,HINKLIN, RONALD JAY,SINGH, AJAY,TURNER, TIMOTHY M.
申请号：
PL08834504
公开号：
PL2209778T3
申请日:
2008.09.15
申请国别(地区):
PL
年份:
2013
代理人:
摘要：
Provided are compounds of Formula I wherein R 2 , R 3 , R 13 , L and D 2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.
